R&D In Brief: Lilly’s Cyramza Cleared In Lung, SABCS & ASH Updates

Lilly adds significant new market for ramucirumab, while early data presented at San Antonio Breast Cancer Symposium and American Society of Hematology annual meeting pave the way for future filings.